Stellus Capital (NYSE: SCM) launches $100M at-the-market offer

Rhea-AI Filing Summary

Stellus Capital Investment Corporation entered into an equity distribution agreement with Keefe, Bruyette & Woods and Raymond James to establish an at-the-market stock offering program. The company may issue and sell from time to time up to $100,000,000 in aggregate offering price of its common shares through these firms as sales agents or to them as principal.

The company plans to use any net proceeds from this at-the-market program to repay outstanding indebtedness and to make investments in portfolio companies consistent with its investment objective and strategies. The sales agents will receive a 1.5% commission on the gross sales price of any shares sold, plus reimbursement of certain expenses. Sales will be made under an effective shelf registration statement on Form N-2 and related prospectus materials.

false 0001551901 0001551901 2025-09-09 2025-09-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 10, 2025 (September 9, 2025)

Stellus Capital Investment Corporation

(Exact Name of Registrant as Specified in Charter)

Maryland		814-00971		46-0937320
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)
4400 Post Oak Parkway, Suite 2200 Houston, Texas				77027
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: (713) 292-5400

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	SCM	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 1.01. Entry into a Material Definitive Agreement.

On September 9, 2025, Stellus Capital Investment Corporation (the “Company”) entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Keefe, Bruyette & Woods, Inc. and Raymond James & Associates, Inc., as sales agents and/or principal thereunder (the “Sales Agents”). Under the Equity Distribution Agreement, the Company may, but has no obligation to, issue and sell, from time to time, up to $100,000,000 in aggregate offering price of shares (the “Shares”) of its common stock, par value $0.001 per share, through the Sales Agents, or to it, as principal for its own account. The Company intends to use the net proceeds from this “at-the-market” offering to repay certain outstanding indebtedness and make investments in portfolio companies in accordance with its investment objective and strategies.

Sales of the Shares, if any, will be made under the prospectus supplement, dated September 9, 2025 (the “Prospectus Supplement”), as may be supplemented from time to time, and the accompany prospectus, dated August 6, 2025 (together with the Prospectus Supplement, including any documents incorporated or deemed to be incorporated by reference therein, the “Prospectus”) by any method permitted by law and deemed to be part of an “at-the-market” offering as defined in Rule 415 under the Securities Act of 1933, as amended, including, without limitation, sales made directly on or through the New York Stock Exchange, or similar securities exchange, or sales made to or through a market maker other than on an exchange, at market prices prevailing at the time of sale, at prices related to prevailing market prices or at other negotiated prices.

Under the terms of the Equity Distribution Agreement, the Sales Agents will receive a commission from the Company equal to 1.5% of the gross sales price of any Shares sold through the Sales Agents under the Equity Distribution Agreement and reimbursement of certain expenses. The Equity Distribution Agreement contains customary representations, warranties and agreements of the Company, indemnification rights and obligations of the parties, and termination provisions.

Further details regarding the Equity Distribution Agreement and the “at-the-market” offering are set forth in the Prospectus filed by the Company with the Securities and Exchange Commission on September 9, 2025.

The Shares, if any, will be offered, issued and sold pursuant to the Company’s shelf registration statement on Form N-2 (File No. 333-288252), the prospectus, dated August 6, 2025, contained therein, and the Prospectus Supplement.

The foregoing description of the Equity Distribution Agreement is not complete and is qualified in its entirety by reference to the full text of the Equity Distribution Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
5.1		Opinion of Eversheds Sutherland (US) LLP.
10.1		Equity Distribution Agreement, dated September 9, 2025, by and among Stellus Capital Investment Corporation and Stellus Capital Management, LLC, on the one hand, and Keefe, Bruyette & Woods, Inc. and Raymond James & Associates, Inc., on the other hand.
23.1		Consent of Eversheds Sutherland (US) LLP (contained in Exhibit 5.1 hereto).
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 10, 2025	Stellus Capital Investment Corporation
	By:	/s/ W. Todd Huskinson
		Name: W. Todd Huskinson
		Title: Chief Financial Officer

FAQ

What did Stellus Capital Investment Corporation (SCM) announce in this 8-K?

Stellus Capital Investment Corporation entered into an equity distribution agreement with Keefe, Bruyette & Woods and Raymond James to set up an at-the-market offering program for its common stock.

How much stock can Stellus Capital (SCM) sell under the at-the-market program?

The company may issue and sell from time to time up to $100,000,000 in aggregate offering price of its common stock under the equity distribution agreement.

What will Stellus Capital use the net proceeds from the ATM offering for?

The company intends to use the net proceeds to repay certain outstanding indebtedness and to make investments in portfolio companies in line with its investment objective and strategies.

Who are the sales agents for Stellus Capital’s at-the-market offering?

The sales agents named in the agreement are Keefe, Bruyette & Woods, Inc. and Raymond James & Associates, Inc., which may act as sales agents and/or principal.

What commissions will the sales agents receive in Stellus Capital’s ATM program?

Under the equity distribution agreement, the sales agents will receive a 1.5% commission on the gross sales price of any shares sold, plus reimbursement of certain expenses.

Under what registration statement is Stellus Capital’s ATM offering being conducted?

The shares, if offered and sold, will be issued under the company’s shelf registration statement on Form N-2 (File No. 333-288252), the related prospectus dated August 6, 2025, and a prospectus supplement dated September 9, 2025.

Does this 8-K itself constitute an offer to sell Stellus Capital securities?

No. The filing states that it does not constitute an offer to sell or a solicitation of an offer to buy securities in any jurisdiction where such an offer or sale would be unlawful.